VOBYXA
LIVE

Serial Number

79443071

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VOBYXA Trademark

Serial Number: 79443071

VOBYXA is a trademark filed by NOVARTIS AG on December 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 9, 2025

Registration Date

Not Registered

Published for Opposition

May 12, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 27, 2026 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 25, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2026 COAR
APPLICATION FILING RECEIPT MAILED
Mar 9, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 9, 2026 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 5, 2026 SDRC